Related Experiment Videos
A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4
D E Brough1, A Lizonova, C Hsu
1GenVec Inc., Rockville, Maryland 20852, USA.
Journal of Virology
|September 1, 1996
Summary
Researchers developed a novel adenovirus vector system by creating complementary cell lines to enhance gene transfer. This system improves virus replication and safety, enabling efficient gene delivery for therapeutic applications.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- Adenovirus vectors are crucial for gene transfer but require improvements for optimal use.
- Key limitations include virus gene expression, limited transgene capacity, and potential replication-competent virus generation.
Purpose of the Study:
- To develop an improved adenovirus vector system for enhanced gene transfer.
- To create a vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Main Methods:
- Constructed cell lines complementing both E1 and E4 by transforming 293 cells with an inducible E4-ORF6 expression cassette.
- Developed E1-/E4- deleted adenovirus vectors (AdRSV beta gal.11 and AdCFTR.11A) for propagation in these cell lines.
- Analyzed vector growth, fiber protein and mRNA accumulation, and replication competence.
Main Results:
- A modified vector (AdCFTR.11A) demonstrated efficient fiber expression and virus yield comparable to E1- vectors.
- The new vector-cell line system eliminated replication-competent virus generation through homologous recombination.
- Second-generation E1-/E4- vectors showed increased transgene capacity and replication incompetence outside complementing cells.
Conclusions:
- The developed vector-cell line system successfully complements E1 and E4 deletions, enhancing adenovirus vector utility.
- This system overcomes limitations of previous vectors, offering improved safety and efficiency for gene therapy.
- AdCFTR.11A represents a promising second-generation adenovirus vector with significant potential for clinical applications.